Nightingale shortlisted for Most Innovative European Biotech SME Awards

Nightingale has been shortlisted for the Most Innovative European Biotech SME Awards (2017) in the “Healthcare Biotech” category. Our CEO, Teemu Suna, has been invited to speak at the awards ceremony, which will be held at the European Parliament in November. 

Nightingale has been shortlisted for the Most Innovative European Biotech SME Awards (2017) in the “Healthcare Biotech” category. Our CEO, Teemu Suna, has been invited to speak at the awards ceremony, which will be held at the European Parliament in November. 

"We’re delighted to be chosen as a finalist by EuropaBio’s jury panel of biotech experts. We believe our innovative technology has the potential to make a considerable contribution to society through improving healthcare diagnostics, particularly in primary care. Representing European SME's and Nightingale’s team at the European Parliament is a unique opportunity and we look forward to demonstrating how our technology can aid clinicians, and ultimately patients themselves, to prevent chronic diseases," says Teemu Suna.  

Nightingale’s service provides health data from blood biomarker analysis, assisting clinicians in providing more personalized guidance to patients. In the long-term, we plan to fully integrate our service into healthcare systems and provide tools for patients to follow-up their own health, enabling preventive healthcare for chronic diseases, such as diabetes and cardiovascular disease. Earlier this year, we were selected as one of the winners of MIT’s (Massachusetts's Institute of Technology) Solve competition, hosted at the United Nations HQ. Nightingale was selected as an official MIT Solver in the Chronic Diseases category.    

The Most Innovative European Biotech SME Award is an annual initiative run by EuropaBio (the European Association for Bioindustries). The awards recognize small and medium European biotech companies (SMEs) for the societal benefits of their innovations and their contributions to Europe’s economy. The awards are one of the highlights of European biotech calendar, with over 200 biotech companies having competed so far.

Stay in the know

Our latest health headlines delivered to your inbox.